TD Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,685	Closed	-$863K	–	1378
2017 Q4	$863K	Sell	12,685 -11,800	-48%	-$825K	﹤0.01%	1084
2017 Q3	$2.02M	Sell	24,485 -18,367	-43%	-$1.46M	﹤0.01%	862
2017 Q2	$4.01M	Buy	42,852 +33,326	+350%	+$2.04M	0.01%	721
2017 Q1	$607K	Sell	9,526 -7,700	-45%	-$468K	﹤0.01%	1168
2016 Q4	$765K	Sell	17,226 -13,474	-44%	-$474K	﹤0.01%	1078
2016 Q3	$1.11M	Sell	30,700 -5,400	-15%	-$116K	﹤0.01%	986
2016 Q2	$495K	Sell	36,100 -500	-1%	-$7.31K	﹤0.01%	1122
2016 Q1	$703K	Sell	36,600 -1,200	-3%	-$25.4K	﹤0.01%	1037
2015 Q4	$1.32M	Sell	37,800 -9,000	-19%	-$580K	﹤0.01%	898
2015 Q3	$4.3M	Sell	46,800 -1,000	-2%	-$86.5K	0.01%	675
2015 Q2	$4.2M	Sell	47,800 -6,200	-11%	-$531K	0.01%	728
2015 Q1	$4.01M	Buy	54,000 +4,200	+8%	+$297K	0.01%	710
2014 Q4	$2.79M	Buy	49,800 +25,100	+102%	+$1.32M	﹤0.01%	793
2014 Q3	$1.12M	Sell	24,700 -1,000	-4%	-$41.8K	﹤0.01%	890
2014 Q2	$1.06M	Buy	25,700 +8,100	+46%	+$417K	﹤0.01%	898
2014 Q1	$1.22M	Buy	17,600 +900	+5%	+$66.1K	﹤0.01%	880
2013 Q4	$1.01M	Buy	16,700 +6,500	+64%	+$354K	﹤0.01%	885
2013 Q3	$620K	Hold	10,200	–	–	﹤0.01%	935
2013 Q2	$683K	Buy	+10,200	New	+$459K	﹤0.01%	888

Other funds holding CLVS